Pricing Log in Create free account

Psychemedics Corporation (PMD) vs XWELL, Inc. (XWEL)

Psychemedics Corporation and XWELL, Inc. are both Diagnostics & Research companies. Psychemedics Corporation is the larger, with a market value of $15.7M against $7.5M — 2.1× the size. XWELL, Inc. grew revenue faster over the last twelve months: −7.58% against −10.9%. Psychemedics Corporation has the higher net margin (−9.45% vs −117.8%) and the lower return on invested capital (−31.4% vs 0.00%). Across the 19 metrics below, Psychemedics Corporation leads on 10 and XWELL, Inc. on 9.

Valuation

Metric PMD XWEL Diagnostics & Research median
P/E n/m n/m 35.56
P/S 0.80 0.22 4.37
P/B 3.05 0.75 3.06
Price to free cash flow 19.46 n/m 35.76
EV/EBITDA 77.29 0.02 24.35
EV/Sales 0.74 (0.01) 5.51
Earnings yield (11.99%) (728.77%) (1.89%)
Free cash flow yield 5.14% (217.51%) (0.15%)

Profitability

Metric PMD XWEL Diagnostics & Research median
Gross margin 36.07% 34.34% 50.89%
Operating margin (9.62%) (61.31%) (8.57%)
Net margin (9.45%) (117.83%) (6.37%)
Free cash flow margin 4.02% (47.65%) 0.00%
Return on equity (31.54%) (557.21%) (2.92%)
Return on assets (18.03%) (155.10%) (6.71%)
Return on invested capital (31.42%) 0.00% 0.00%

Growth

Metric PMD XWEL Diagnostics & Research median
Revenue growth (TTM) (10.92%) (7.58%) 7.69%
EPS growth (last fiscal year) 55.56% (38.80%) 25.92%
Revenue growth, 5-year CAGR (12.18%) 28.35% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PMD XWEL Diagnostics & Research median
Debt to equity 0.01 0.00 0.11
Current ratio 1.82 2.27 2.02
Net debt to EBITDA (7.26) (0.08) 0.70

Dividend

Metric PMD XWEL Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric PMD XWEL Diagnostics & Research median
Market cap 15.70m 7.45m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack